通過對病理切片的觀察,可以發(fā)現(xiàn)經(jīng)中藥治療后各劑量組上氣道炎癥及肺組織病理癥狀與模型組相比均有改善,其作用與劑量成正相關性。特別是大劑量組病理改變明顯減輕,支氣管周圍和黏膜層及肺泡區(qū)結(jié)構(gòu)基本正常,無明顯炎性細胞浸潤,氣道、血管平滑肌及肺泡壁無明顯增厚,肺泡腔無明顯改變。證實健兒強身膏具有抑制氣道、肺組織炎癥作用,其作用效果類似地塞米松。
【參考文獻】
[1] 黃泰康. 中醫(yī)哮病學[M]. 北京:中國醫(yī)藥科技出版社,2002:3-5.
[2] 劉 靜. 具有免疫增強作用的中藥藥理分析[J].醫(yī)學導報,2003,22(增刊):71-72.
[3] 張 麗. 扶正補氣方對實驗動物NKC-IFN-IL-2調(diào)節(jié)網(wǎng)的作用[J]. 北京中醫(yī)學院學報,1991,14(增刊):30-32.
[4] 馮 璞. 四君子湯對小鼠腹腔巨噬細胞功能的調(diào)節(jié)作用[J]. 甘肅醫(yī)藥,1991,10(3):135-137.
[5] 李明華,殷凱生,朱檢立,主編.哮喘病學[M].1版. 北京:人民衛(wèi)生出版社,1999:36-38.
[6] Saerra M,Turato G. Airway pathology in asthma[J]. Eur Respir J,2001,34(Suppl):18-23.
[7] Lacy P,Moqbel R. Immune effector functions of eosinophils in allergic airway inflammation[J]. Curr Opin Allergy Clin Immunol, 2001,1(1):79-84醫(yī).學全.在.線網(wǎng)站m.gydjdsj.org.cn.
[8] Clark K,Simson L,Newcombe N,et al. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen[J]. J Leukoc Biol,2004,75(6):1001-1009.
[9] Shen HH,Ochkur SI,Mc Garry MP,et al. A causative relationship exists between eosiophils and the development of allergic pulmonary pathologies in the mouse[J]. J Immunol,2003,170(6):3296-3305.
[10] 冼華浩,鐘南山,萬歡莢,等.哮喘手冊[M].北京:人民衛(wèi)生出版社,2004:23-25.
[11] Woolley KL,Gibson PG,Carty K,et al. Eosinophilap optosisa ndth eres olutiono fa irwayin flammationin a sthma[J]. Am J Respir Crit Care Med, 1996,154(1):237-243.
[12] Wallen N,Kita H,Weiler D,et al. Glucocorticoids inhibit cytokinemediated eosinophil survival[J]. J Immunol,1991, 147(10):3490-3495.
[13] 鄧立力,邵玉霞,楊 敏.地塞米松對哮喘大鼠氣道重塑及基質(zhì)金屬蛋白酶-9表達的影響[J]. 哈爾濱醫(yī)科大學學報,2004,38(1):61-64.